Establishment Labs Holdings Inc
Research Establishment Labs Holdings Inc (ESTA) on Bullrun: market cap USD 2.12B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerESTA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 2.12B
- Financial periodQ2 2026
- RevenueUSD 67.54M
- Net income-USD 11.75M
- Free cash flow-USD 20.25M
- Gross margin70.6%
Valuation Snapshot
latest market cap is USD 2.12B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 211.08M | -USD 51.06M | -USD 56.94M | 69.3% | -1.72 | USD 75.57M | USD 247.52M | USD 23.55M |
| FY2024 | USD 166.03M | -USD 84.60M | -USD 64.63M | 66.0% | -3 | USD 90.35M | USD 219.58M | USD 53.10M |
| FY2023 | USD 165.15M | -USD 78.50M | -USD 96.42M | 64.8% | -3.07 | USD 40.04M | USD 188.74M | USD 18.40M |
| FY2022 | USD 161.70M | -USD 75.21M | -USD 55.02M | 65.9% | -3.08 | USD 66.36M | USD 175.46M | -USD 8.19M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.12B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.14B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.33B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 668.18M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.60B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.63B | n/a | n/a | n/a |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Establishment Labs Holdings Inc's market cap?
Establishment Labs Holdings Inc's market capitalization is USD 2.12B.
What does Establishment Labs Holdings Inc do?
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.